Skip to content
Recall Observatory FDA recall evidence

Drug product

Ondansetron Injection, USP, 4mg/2mL, (2mg/ml), 2mL single-dose Fliptop Vial, Rx only, Sterile, NDC 0409-4755-03, Hospira, Inc, Lake Forest, IL 60045.

D-851-2013

May 20, 2013

Class II

Product summary

Firm
Hospira, Inc.
Event
Event 65300
Status
Terminated
Classification
Class II
Quantity
340,600 vials
Official record key
drug-enforcement:D-851-2013

Official wording

Reason: Presence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lot

Code information: Lot 25394DK, exp. 01/2015

Distribution pattern: Nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate